Cargando…
S167: EFFICACY AND SAFETY OF LUSPATERCEPT FOR THE TREATMENT OF ANEMIA IN PATIENTS WITH MYELOFIBROSIS: RESULTS FROM THE ACE-536-MF-001 STUDY
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428334/ http://dx.doi.org/10.1097/01.HS9.0000967580.08826.11 |
| _version_ | 1785090443658133504 |
|---|---|
| author | Gerds, Aaron T. Harrison, Claire Kiladjian, Jean-Jacques Mesa, Ruben Vannucchi, Alessandro Komrokji, Rami S. Bose, Prithviraj Kremyanskaya, Marina Mead, Adam Gotlib, Jason Sanabria, Fabian Marsousi, Niloufar Giuseppi, Ana Carolina Jiang, Huijing Palmer, Jeanne Mccaul, Kelly Ribrag, Vincent Verstovsek, Srdan Passamonti, Francesco |
| author_facet | Gerds, Aaron T. Harrison, Claire Kiladjian, Jean-Jacques Mesa, Ruben Vannucchi, Alessandro Komrokji, Rami S. Bose, Prithviraj Kremyanskaya, Marina Mead, Adam Gotlib, Jason Sanabria, Fabian Marsousi, Niloufar Giuseppi, Ana Carolina Jiang, Huijing Palmer, Jeanne Mccaul, Kelly Ribrag, Vincent Verstovsek, Srdan Passamonti, Francesco |
| author_sort | Gerds, Aaron T. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428334 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104283342023-08-17 S167: EFFICACY AND SAFETY OF LUSPATERCEPT FOR THE TREATMENT OF ANEMIA IN PATIENTS WITH MYELOFIBROSIS: RESULTS FROM THE ACE-536-MF-001 STUDY Gerds, Aaron T. Harrison, Claire Kiladjian, Jean-Jacques Mesa, Ruben Vannucchi, Alessandro Komrokji, Rami S. Bose, Prithviraj Kremyanskaya, Marina Mead, Adam Gotlib, Jason Sanabria, Fabian Marsousi, Niloufar Giuseppi, Ana Carolina Jiang, Huijing Palmer, Jeanne Mccaul, Kelly Ribrag, Vincent Verstovsek, Srdan Passamonti, Francesco Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428334/ http://dx.doi.org/10.1097/01.HS9.0000967580.08826.11 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Oral Sessions Gerds, Aaron T. Harrison, Claire Kiladjian, Jean-Jacques Mesa, Ruben Vannucchi, Alessandro Komrokji, Rami S. Bose, Prithviraj Kremyanskaya, Marina Mead, Adam Gotlib, Jason Sanabria, Fabian Marsousi, Niloufar Giuseppi, Ana Carolina Jiang, Huijing Palmer, Jeanne Mccaul, Kelly Ribrag, Vincent Verstovsek, Srdan Passamonti, Francesco S167: EFFICACY AND SAFETY OF LUSPATERCEPT FOR THE TREATMENT OF ANEMIA IN PATIENTS WITH MYELOFIBROSIS: RESULTS FROM THE ACE-536-MF-001 STUDY |
| title | S167: EFFICACY AND SAFETY OF LUSPATERCEPT FOR THE TREATMENT OF ANEMIA IN PATIENTS WITH MYELOFIBROSIS: RESULTS FROM THE ACE-536-MF-001 STUDY |
| title_full | S167: EFFICACY AND SAFETY OF LUSPATERCEPT FOR THE TREATMENT OF ANEMIA IN PATIENTS WITH MYELOFIBROSIS: RESULTS FROM THE ACE-536-MF-001 STUDY |
| title_fullStr | S167: EFFICACY AND SAFETY OF LUSPATERCEPT FOR THE TREATMENT OF ANEMIA IN PATIENTS WITH MYELOFIBROSIS: RESULTS FROM THE ACE-536-MF-001 STUDY |
| title_full_unstemmed | S167: EFFICACY AND SAFETY OF LUSPATERCEPT FOR THE TREATMENT OF ANEMIA IN PATIENTS WITH MYELOFIBROSIS: RESULTS FROM THE ACE-536-MF-001 STUDY |
| title_short | S167: EFFICACY AND SAFETY OF LUSPATERCEPT FOR THE TREATMENT OF ANEMIA IN PATIENTS WITH MYELOFIBROSIS: RESULTS FROM THE ACE-536-MF-001 STUDY |
| title_sort | s167: efficacy and safety of luspatercept for the treatment of anemia in patients with myelofibrosis: results from the ace-536-mf-001 study |
| topic | Oral Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428334/ http://dx.doi.org/10.1097/01.HS9.0000967580.08826.11 |
| work_keys_str_mv | AT gerdsaaront s167efficacyandsafetyofluspaterceptforthetreatmentofanemiainpatientswithmyelofibrosisresultsfromtheace536mf001study AT harrisonclaire s167efficacyandsafetyofluspaterceptforthetreatmentofanemiainpatientswithmyelofibrosisresultsfromtheace536mf001study AT kiladjianjeanjacques s167efficacyandsafetyofluspaterceptforthetreatmentofanemiainpatientswithmyelofibrosisresultsfromtheace536mf001study AT mesaruben s167efficacyandsafetyofluspaterceptforthetreatmentofanemiainpatientswithmyelofibrosisresultsfromtheace536mf001study AT vannucchialessandro s167efficacyandsafetyofluspaterceptforthetreatmentofanemiainpatientswithmyelofibrosisresultsfromtheace536mf001study AT komrokjiramis s167efficacyandsafetyofluspaterceptforthetreatmentofanemiainpatientswithmyelofibrosisresultsfromtheace536mf001study AT boseprithviraj s167efficacyandsafetyofluspaterceptforthetreatmentofanemiainpatientswithmyelofibrosisresultsfromtheace536mf001study AT kremyanskayamarina s167efficacyandsafetyofluspaterceptforthetreatmentofanemiainpatientswithmyelofibrosisresultsfromtheace536mf001study AT meadadam s167efficacyandsafetyofluspaterceptforthetreatmentofanemiainpatientswithmyelofibrosisresultsfromtheace536mf001study AT gotlibjason s167efficacyandsafetyofluspaterceptforthetreatmentofanemiainpatientswithmyelofibrosisresultsfromtheace536mf001study AT sanabriafabian s167efficacyandsafetyofluspaterceptforthetreatmentofanemiainpatientswithmyelofibrosisresultsfromtheace536mf001study AT marsousiniloufar s167efficacyandsafetyofluspaterceptforthetreatmentofanemiainpatientswithmyelofibrosisresultsfromtheace536mf001study AT giuseppianacarolina s167efficacyandsafetyofluspaterceptforthetreatmentofanemiainpatientswithmyelofibrosisresultsfromtheace536mf001study AT jianghuijing s167efficacyandsafetyofluspaterceptforthetreatmentofanemiainpatientswithmyelofibrosisresultsfromtheace536mf001study AT palmerjeanne s167efficacyandsafetyofluspaterceptforthetreatmentofanemiainpatientswithmyelofibrosisresultsfromtheace536mf001study AT mccaulkelly s167efficacyandsafetyofluspaterceptforthetreatmentofanemiainpatientswithmyelofibrosisresultsfromtheace536mf001study AT ribragvincent s167efficacyandsafetyofluspaterceptforthetreatmentofanemiainpatientswithmyelofibrosisresultsfromtheace536mf001study AT verstovseksrdan s167efficacyandsafetyofluspaterceptforthetreatmentofanemiainpatientswithmyelofibrosisresultsfromtheace536mf001study AT passamontifrancesco s167efficacyandsafetyofluspaterceptforthetreatmentofanemiainpatientswithmyelofibrosisresultsfromtheace536mf001study |